Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our divisions - Innovative Medicines and Sandoz - are supported by functional organizations with global scale.
Made up of two business units – Novartis Pharmaceuticals, which includes Novartis Gene Therapies, and Novartis Oncology – our Innovative Medicines division commercializes innovative patented medicines to enhance health outcomes for patients and healthcare professionals.
Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.
Advanced Accelerator Applications
Advanced Accelerator Applications is a Novartis company focused exclusively on radioligand therapy and precision imaging.